Safety and Efficacy Study of Citalopram and Lithium for the Treatment of Depressive Mood Disorder Symptoms

Phase 2 Completed 80 enrolled Columbia Northwest Pharmaceuticals

RandomizedParallel-groupQuadruple-blindTreatment

Summary

The investigators hypothesize that patients receiving citalopram in combination with lithium will have a greater reduction in depressive symptoms than patients receiving citalopram in combination with placebo.

Timeline

Start: 2010-03
Primary completion: 2011-01
Completion: 2011-01

Drugs

Evaluation	Drug	Modality	Dose	Route
Comparator	Citalopram	Small molecule	20 mg	Oral
Comparator	Lithium Carbonate	Unknown	300 mg	—

Safety and Efficacy Study of Citalopram and Lithium for the Treatment of Depressive Mood Disorder Symptoms

Summary

Timeline

Drugs

Indications